LISCure Biosciences Inc.
PrivateLast Round
Growth Equity
Jan 10, 2025
Est. Valuation
$80.6M
Total Funding Raised
$40.1M
Company Overview
LISCure Biosciences Inc. is a clinical-stage pharmaceutical company developing injectable bacteria-mediated cancer immunotherapy and oral microbiome therapeutics for diseases including oncology, liver diseases, neuroscience, and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LISCure Biosciences Inc. Comps
Public and private peers based on sector, stage, and business model.
LISCure Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 10, 2025 | ||||
| Series B | Feb 25, 2021 | ||||
| Seed | Jul 25, 2019 |
Key People
Founding team and executive leadership
LISCure Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Securities | Seed |
| InterValue Partners | Growth Equity |
| NHN Investment | Seed |
| IBK Securities | Growth Equity |
| Yukyung PSG Asset Management | Growth Equity |
| Muirwoods Ventures | Growth Equity |
LISCure Biosciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LISCure Biosciences Inc.'s valuation, stock price, and market status.
